Immune thrombocytopenia in children with reference to low income countries
EMHJ-Eastern Mediterranean Health Journal. 2009; 15 (3): 729-737
em En
| IMEMR
| ID: emr-157374
Biblioteca responsável:
EMRO
ABSTRACT
Immune thrombocytopenia is a benign and self-limiting disorder. Data about the condition and its incidence from low-income countries is limited. This paper reviews the research about immune thrombocytopenia, comparing low- and high-income countries. Diagnosis is usually based on complete blood count and peripheral smear and, in selected cases, bone marrow aspiration. The disease has a high remission rate both in high- and low-income countries and intracranial haemorrhage is rare. The recommended treatment is simply observation of cases, especially when the platelet count is > 10 000 /mm[3]. If drug therapy is required, oral steroids are the most economical choice
Buscar no Google
Índice:
IMEMR
Assunto principal:
Incidência
/
Resultado do Tratamento
/
Imunoglobulinas Intravenosas
/
Análise Custo-Benefício
/
Hemorragias Intracranianas
/
Países em Desenvolvimento
/
Diagnóstico Diferencial
/
Glucocorticoides
Tipo de estudo:
Incidence_studies
Limite:
Humans
Idioma:
En
Revista:
East Mediterr Health J.
Ano de publicação:
2009